Neuroscience Drug Development Europe
A 2-day event addressing emerging strategies for drug development within Neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases.
A 2-day event addressing emerging strategies for drug development within Neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases.
Listen to our talk or pop by our booth!
Come and visit our team at our booth #28 to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.
Talk:
Speaker: Manos Metzakopian, PhD, VP, Research and Development
Listen to our talk 'opti-ox™ 'Revolutionising Cell Manufacturing for Drug Discovery and Cell Therapy' in the Neuroscience programme on day one at 9:20am: Track 5 'Therapeutic strategies, enabling technologies & Biomarker development':
- Hear first-hand experience of the challenges in differentiating human iPS cells and the need for a new method of generation
- Learn how a new approach to generating human iPSC-derived cells solves the major cell manufacturing bottlenecks of purity, consistency and scalability
- See characterisation and functional data from this new approach demonstrating the manufacture of cells with a single, defined identity at unprecedented levels of consistency
- You will also learn how to partner with bit.bio to develop your own cells powered by opti-ox.
Arrange a meeting